Difference between revisions of "Corticobasal syndrome / corticobasal degeneration"
(Created page with "'''Diagnosis''' CBS clinical criteria 111 (note that other clinical phenotypes, including FBS, naPPA, and PSP may also have CBD pathology) 1) Probable CBS :a. Must have asy...") |
Rishabaiims (talk | contribs) |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| + | Note: corticobasal syndrome (CBS) refers to the constellation of symptoms reflective of a clinical phenotype. Corticobasal degeneration refers to the underlying neuropathology. Corticobasal syndrome is not exclusively the result of corticobasal degeneration, and similarly, corticobasal degeneration does not always present as corticobasal syndrome. | ||
| + | |||
'''Diagnosis''' | '''Diagnosis''' | ||
| − | CBS clinical criteria | + | CBS clinical criteria (Armstrong 2013) (note that other clinical phenotypes, including FBS (Frontal Behavioral-Spatial Syndrome, mimics bvFTD), nfPPA, and PSP may also have CBD pathology) |
1) Probable CBS | 1) Probable CBS | ||
| Line 43: | Line 45: | ||
::iii. Alien limb phenomena (more than simple levitation) | ::iii. Alien limb phenomena (more than simple levitation) | ||
| − | - patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction | + | - patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction (Finger 2016) |
| − | - neuroimaging shows asymmetric frontal and parietal lobe atrophy | + | - neuroimaging shows asymmetric frontal and parietal lobe atrophy (Finger 2016 |
| − | Other possible presentations of underlying corticobasal degeneration pathology: | + | Other possible presentations of underlying corticobasal degeneration pathology: (Armstrong 2013) |
1) Frontal behavioral-spatial syndrome | 1) Frontal behavioral-spatial syndrome | ||
| Line 60: | Line 62: | ||
::iii. Visuospatial deficits | ::iii. Visuospatial deficits | ||
| − | 2) | + | 2) [[Nonfluent / agrammatic variant primary progressive aphasia]] |
| − | 3) | + | 3) [[Progressive supranuclear palsy (Steele-Richardson-Olszewski)]] |
'''Pathology''' | '''Pathology''' | ||
| − | Proposed pathologic criteria for the diagnosis of CBD require: | + | |
| + | Proposed pathologic criteria for the diagnosis of CBD require: (Armstrong 2013) | ||
| + | |||
:a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter | :a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter | ||
| Line 78: | Line 82: | ||
== References == | == References == | ||
| + | |||
| + | Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496–503 (2013). https://pubmed.ncbi.nlm.nih.gov/23359374/ | ||
| + | |||
| + | Finger, E. C. Frontotemporal Dementias. Contin. Minneap. Minn 22, 464–489 (2016). https://pubmed.ncbi.nlm.nih.gov/27042904/ | ||
Latest revision as of 17:35, 5 August 2022
Note: corticobasal syndrome (CBS) refers to the constellation of symptoms reflective of a clinical phenotype. Corticobasal degeneration refers to the underlying neuropathology. Corticobasal syndrome is not exclusively the result of corticobasal degeneration, and similarly, corticobasal degeneration does not always present as corticobasal syndrome.
Diagnosis
CBS clinical criteria (Armstrong 2013) (note that other clinical phenotypes, including FBS (Frontal Behavioral-Spatial Syndrome, mimics bvFTD), nfPPA, and PSP may also have CBD pathology)
1) Probable CBS
- a. Must have asymmetric presentation
- b. Must have at least two of the following:
- i. Limb rigidity or akinesia
- ii. Limb dystonia
- iii. Limb myoclonus
- c. Must have at least two of the following:
- i. Orobuccal or limb apraxia
- ii. Cortical sensory deficit (i.e. agraphesthesia, astereognosis)
- iii. Alien limb phenomena (more than simple levitation)
2) Possible CBS
- a. Must have asymmetric presentation
- b. Must have at least one of the following:
- i. Limb rigidity or akinesia
- ii. Limb dystonia
- iii. Limb myoclonus
- c. Must have at least one of the following:
- i. Orobuccal or limb apraxia
- ii. Cortical sensory deficit
- iii. Alien limb phenomena (more than simple levitation)
- patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction (Finger 2016)
- neuroimaging shows asymmetric frontal and parietal lobe atrophy (Finger 2016
Other possible presentations of underlying corticobasal degeneration pathology: (Armstrong 2013)
1) Frontal behavioral-spatial syndrome
- a. Must have at least two of the following:
- i. Executive dysfunction
- ii. Behavioral or personality changes
- iii. Visuospatial deficits
2) Nonfluent / agrammatic variant primary progressive aphasia
3) Progressive supranuclear palsy (Steele-Richardson-Olszewski)
Pathology
Proposed pathologic criteria for the diagnosis of CBD require: (Armstrong 2013)
- a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter
- b) In conjunction with neuronal loss in focal cortical regions and in the substantia nigra
- c) Supportive features include ballooned cortical neurons, cortical atrophy, and tau-positive oligodendroglial coiled bodies
- pathology is typically 4R tau (CBD) > (Alzheimer’s pathology) > PSP, TDP-43 > 3R tau 92
References
Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496–503 (2013). https://pubmed.ncbi.nlm.nih.gov/23359374/
Finger, E. C. Frontotemporal Dementias. Contin. Minneap. Minn 22, 464–489 (2016). https://pubmed.ncbi.nlm.nih.gov/27042904/
